ALRUBICIN 50MG INJECTION contains Epirubicin which belongs to the group of medicines called Anticancer agents. It is used to manage various types of cancer such as breast cancer, ovarian cancer, gastric cancer (stomach cancer), small cell lung cancer, head and neck cancer, liver cancer, blood cancer (leukemia), lymph cancer (lymphoma), pancreatic cancer and colorectal cancer (cancers of colon or rectum).
It can also be used to manage cancers of soft tissues such as soft tissues sarcoma (cancer of the soft tissues that connects muscles, fats, blood vessels, nerves, tendons etc.) and helps to stop the occurrence of bladder cancer following surgeries (such as transurethral resection).
Before receiving ALRUBICIN 50MG INJECTION inform your doctor if you have any liver, kidney or heart problems. You must also inform your doctor if you have any severe infections, low blood count or any bladder problems (such as problems in passing urine, burning sensation while passing urine etc.) as a precaution.
ALRUBICIN 50MG INJECTION is not recommended for use in pregnant or breastfeeding women. Both men and women of childbearing potential must use a suitable contraceptive to avoid pregnancy while undergoing therapy with this medicine. Men may seek advice on sperm preservation, if necessary, prior to the therapy with this medicine.
The most common side effects of receiving ALRUBICIN 50MG INJECTION are hair loss, red urine, increased infection, hot flashes, mouth ulcers, inflammation of oesophagus, nausea, vomiting (within first 24 hours), loss of appetite, bladder infection, burning sensation while passing urine and pain, redness and swelling at the site of injection. Consult your doctor if any of these side effects trouble you.
No content available
